TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15792014

Group type: EXPERIMENTAL
Intervention: Vitamin, macro and microelement supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-supplemented group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 11795353

Group type: EXPERIMENTAL
Intervention: Raloxifene (SERM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifestyle and dietary changes (increasing weight-bearing activity, enhancing calcium and vitamin D intake)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen/progestin therapy
Number of subjects: 0
Study: 9692698

Group type: EXPERIMENTAL
Intervention: Mosapride 40 mg q.d.s. for 2 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 7919152

Group type: EXPERIMENTAL
Intervention: Caffeine (adenosine-receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3079536

Group type: EXPERIMENTAL
Intervention: Oral glucose/electrolyte solution designed for maintenance of hydration (Na+ concentration 45 mmol/l)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Oral glucose/electrolyte solution designed for fluid replacement (Na+ concentration 75 mmol/l)
Number of subjects: 54
Study: 30064398

Group type: EXPERIMENTAL
Intervention: 12-month behavioral change intervention adapted from PREMIER
Number of subjects: 140

Group type: COMPARATOR
Intervention: Delayed intervention (Arm 2)
Number of subjects: 140
Study: 26504195

Group type: EXPERIMENTAL
Intervention: BMI <18.5 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI 22.5-24.9 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI 25-27.4 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI 27.5-29.9 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI 30-34.9 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI 35-39.9 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: BMI >40 kg/m2
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: Genetically determined BMI increase (per unit)
Number of subjects: 85437

Group type: EXPERIMENTAL
Intervention: Observational BMI increase (per unit)
Number of subjects: 85437
Study: 24885548

Group type: EXPERIMENTAL
Intervention: Simplified Airway Risk Index (SARI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual non‐specific assessment
Number of subjects: 28
Study: 23327961

Group type: EXPERIMENTAL
Intervention: Urethral sphincter electromyography (US‐EMGs) in MSA patients
Number of subjects: 15
Study: 22166652

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 14
Study: 18758747

Group type: EXPERIMENTAL
Intervention: Targeted, one-to-one education
Number of subjects: 172
Study: 15544281

Group type: EXPERIMENTAL
Intervention: VR simulation and multimedia educational tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multimedia educational tool only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11557312

Group type: EXPERIMENTAL
Intervention: Vitamin C (12.5 mg/kg body weight) and N-acetyl-cysteine (10 mg/kg body weight) for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9663892

Group type: EXPERIMENTAL
Intervention: 5 mg folic acid and 4 g betaine daily for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5 mg folic acid daily for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 or 5 mg folic acid daily for 40 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 or 5 mg folic acid daily for 52 weeks
Number of subjects: 30
Study: 7852661

Group type: EXPERIMENTAL
Intervention: 1.5 mg cyanocobalamin (3 x/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 3163217

Group type: EXPERIMENTAL
Intervention: Circumferential supracrestal fiberotomy (CSF) procedure
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (no CSF procedure)
Number of subjects: 320
Study: 30125124

Group type: EXPERIMENTAL
Intervention: MacIntosh tenodesis with 20 N graft tension and tibia free to rotate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MacIntosh tenodesis with 80 N graft tension and tibia free to rotate
Number of subjects: 8

Group type: COMPARATOR
Intervention: MacIntosh tenodesis with 20 N graft tension and fixed tibial rotation
Number of subjects: 8

Group type: COMPARATOR
Intervention: MacIntosh tenodesis with 80 N graft tension and fixed tibial rotation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sectioning of the anterolateral complex
Number of subjects: 8
Study: 26228939

Group type: EXPERIMENTAL
Intervention: 20 mg Methylphenidate (MPH)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 23300127

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy for Antidepressants (META)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 50
Study: 21361737

Group type: EXPERIMENTAL
Intervention: Ingesting 10 tablets (four acetaminophen, four ibuprofen, and two multivitamin tablets) with 500 ml of water
Number of subjects: 15

Group type: COMPARATOR
Intervention: Drinking 500 ml of water alone (control group)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ultrasonography technique
Number of subjects: 15
Study: 18082496

Group type: EXPERIMENTAL
Intervention: C + ASA
Number of subjects: 70

Group type: COMPARATOR
Intervention: ASA
Number of subjects: 70
Study: 16483870

Group type: EXPERIMENTAL
Intervention: Amino Acid (AA) supplementation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 17
Study: 12538743

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg orally for 6 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg orally for 6 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no antihypertensive drugs except diuretics)
Number of subjects: 10
Study: 11195946

Group type: EXPERIMENTAL
Intervention: Study doctors interpreting tympanograms
Number of subjects: 242

Group type: COMPARATOR
Intervention: Curves taken during pre-scheduled healthy visits
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Concurrent knowledge of clinical ear status
Number of subjects: 242

Group type: COMPARATOR
Intervention: Audiologist interpreting tympanograms
Number of subjects: 242
Study: 9123730

Group type: EXPERIMENTAL
Intervention: Repeat sextant biopsy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Negative repeat biopsy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Positive repeat biopsy
Number of subjects: 89
Study: 8349185

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no GM-CSF)
Number of subjects: 11
Study: 3812946

Group type: EXPERIMENTAL
Intervention: 40 ml 0.5% prilocaine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 ml 1% prilocaine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 ml 1% prilocaine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (100% flexion remaining)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 400 mg prilocaine
Number of subjects: 6
Study: 31539292

Group type: EXPERIMENTAL
Intervention: BCI condition (commercial EEG-based BCI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Traditional condition (standard keyboard and mouse interface)
Number of subjects: 26
Study: 29575488

Group type: EXPERIMENTAL
Intervention: Internal connection and microthreads on the implant neck (I MT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Internal connection, no microthreads (I NMT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: External connection, with microthreads (E MT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: External connection, without microthreads (E NMT)
Number of subjects: 21
Study: 26345106

Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus 375 mg amoxicillin and 250 mg metronidazole for 7 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Scaling and root planing + placebo
Number of subjects: 39
Study: 23905537

Group type: EXPERIMENTAL
Intervention: Therapist responsiveness in the first two sessions of therapy (Cognitive Behavior Therapy and Interpersonal Psychotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative therapist behavior factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapist attentiveness and early empathic responding
Number of subjects: 0
Study: 22476270

Group type: EXPERIMENTAL
Intervention: Education and feedback intervention in group A (5 units) during intervention period 1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group B (5 units) during intervention period 2
Number of subjects: 10
Study: 20124051

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate therapy for 28 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: No iron therapy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate therapy
Number of subjects: 300
Study: 19103540

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) added to induction cardioplegia solution at a dose of 4 mmol/l and to maintenance cardioplegia solution at a dose of 2 mmol/l
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 30
Study: 15614301

Group type: EXPERIMENTAL
Intervention: Endovenous sedation
Number of subjects: 197

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 197
Study: 11127492

Group type: EXPERIMENTAL
Intervention: Educational group sessions and individual sessions administered by a trained nurse and physiotherapist for COPD patients.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no educational intervention) for COPD patients.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Educational intervention for asthmatics.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no educational intervention) for asthmatics.
Number of subjects: 140
Study: 9344484

Group type: EXPERIMENTAL
Intervention: Retrieval cue exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased exposure to retrieval cue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Retention intervals associated with remote memory
Number of subjects: 0

Group type: COMPARATOR
Intervention: Retention intervals associated with intermediate memory
Number of subjects: 0
Study: 8455046

Group type: EXPERIMENTAL
Intervention: Decisional aid for mental capacity assessments
Number of subjects: 64

Group type: COMPARATOR
Intervention: No decisional aid (Control)
Number of subjects: 64
Study: 3101243

Group type: EXPERIMENTAL
Intervention: Intramuscular iron dextran prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31439101

Group type: EXPERIMENTAL
Intervention: Factual gain‐framed message
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Factual loss‐framed message
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Emotional gain‐framed message
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Emotional loss‐framed message
Number of subjects: 402
Study: 29089053

Group type: EXPERIMENTAL
Intervention: Fluralaner (1.5 mg/kg body weight, 4 administrations, 7 days apart)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control (non-medicated drinking water)
Number of subjects: 432
Study: 26474617

Group type: EXPERIMENTAL
Intervention: Emergency surgery (Group A) within 6 hours after injury
Number of subjects: 40

Group type: COMPARATOR
Intervention: Selective surgery (Group B) after close reduction and improvement of soft tissue condition
Number of subjects: 40
Study: 24019110

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered simultaneously with glimepiride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered simultaneously with glipizide ER
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered simultaneously with olmesartan medoxomil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered 4 hours before glimepiride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered 4 hours before glipizide ER
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colesevelam (3,750 mg once daily) administered 4 hours before olmesartan medoxomil
Number of subjects: 0
Study: 21781231

Group type: EXPERIMENTAL
Intervention: Zinc-aluminium ointment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 20087302

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (0.8% BCAA in a 3.5% carbohydrate solution; 2,500 mL/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo drink (isocaloric)
Number of subjects: 12
Study: 17535868

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: No treatment (untreated TS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 8
Study: 15008021

Group type: EXPERIMENTAL
Intervention: Acupuncture Group (AG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nerve Stimulation Group (NSG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 15
Study: 10730601

Group type: EXPERIMENTAL
Intervention: Actor of mixed race (Hispanic-black)
Number of subjects: 231

Group type: COMPARATOR
Intervention: White actor
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Female actress
Number of subjects: 231

Group type: COMPARATOR
Intervention: Male actor
Number of subjects: 231
Study: 9168213

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg administered directly in the surgical site (mixed with local anesthetic)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ketorolac 60 mg administered via the parenteral route
Number of subjects: 30
Study: 1438525

Group type: COMPARATOR
Intervention: Cimetidine (400 mg b.d.)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg b.d.) with MMSC (500 mg four times daily)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg b.d.) with cysteine (200 mg four times daily)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Cimetidine at night (maintenance)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cimetidine with MMSC (maintenance)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cimetidine with cysteine (maintenance)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Cimetidine alone (previous treatment)
Number of subjects: 238
Study: 2410683

Group type: EXPERIMENTAL
Intervention: Prazosin (5.7 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31074201

Group type: COMPARATOR
Intervention: Intralesional corticosteroids (ILCs)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (ILCs and PRP)
Number of subjects: 80
Study: 28929782

Group type: EXPERIMENTAL
Intervention: Autobiographical memory intervention (Precious Memories)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control condition (individual unstructured contacts with a volunteer)
Number of subjects: 86
Study: 25515163

Group type: EXPERIMENTAL
Intervention: Classical method of esophageal speech therapy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Simplified animation of air movements method using MII
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both groups (Classical and Simplified methods)
Number of subjects: 26
Study: 25619206

Group type: EXPERIMENTAL
Intervention: Everted closure using interrupted subcuticular sutures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planar closure
Number of subjects: 0
Study: 23808506

Group type: COMPARATOR
Intervention: Epidural analgesia (bolus of 8 to 15 ml of ropivacaine 0.2% and infusion of 5 to 15 ml/hour for three days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block (bolus dose of 20 ml of ropivacaine 0.375% bilaterally and infusion of 0.2% ropivacaine 8 ml/hour bilaterally for three days)
Number of subjects: 42
Study: 20623443

Group type: EXPERIMENTAL
Intervention: Fiber-free diet (FFD) with polyethylene glycol electrolyte solution (PEG-ES)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clear-liquid diet (CLD) with polyethylene glycol electrolyte solution (PEG-ES)
Number of subjects: 200
Study: 18972726

Group type: EXPERIMENTAL
Intervention: Substance-partitioned moxibustion
Number of subjects: 209

Group type: COMPARATOR
Intervention: Chinese drug Yueyue-shu (Control)
Number of subjects: 209
Study: 16377669

Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg) alone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Linezolid (600 mg) with antacid (Maalox containing 600 mg magnesium hydroxide and 900 mg aluminum hydroxide)
Number of subjects: 18
Study: 12754130

Group type: EXPERIMENTAL
Intervention: Methotrexate 12.3±3.6 mg once a week + Meloxicam 7.5 mg for 3 months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Methotrexate 21.3±3.2 mg once a week + Meloxicam 7.5 mg for 3 months
Number of subjects: 32
Study: 10780764

Group type: EXPERIMENTAL
Intervention: Air pollution exposure in road tunnel (NO2 levels > or = 300 microg x m‐3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Air pollution exposure in road tunnel (PM2.5 levels > or = 100 microg x m‐3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control exposure in suburban area (lower pollution levels)
Number of subjects: 20
Study: 8967757

Group type: EXPERIMENTAL
Intervention: 0.5 micrograms/kg/day rhCNTF
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 2 micrograms/kg/day rhCNTF
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg/day rhCNTF
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study: 1330676

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (0.5 mg/ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2.5 mg/ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (10 mg/ml)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31095117

Group type: EXPERIMENTAL
Intervention: 20 mL 0.5% ropivacaine and 1 ug/kg of dexmedetomidine (group RD)
Number of subjects: 57

Group type: COMPARATOR
Intervention: 20 mL 0.5% ropivacaine (group R)
Number of subjects: 57
Study: 28339165

Group type: EXPERIMENTAL
Intervention: Sodium citrate nasal spray
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 55
Study: 25859431

Group type: EXPERIMENTAL
Intervention: ReCog intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 29
Study: 23876559

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) at 25Hz and peak to peak displacement of 4mm
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No Whole Body Vibration (noWBV)
Number of subjects: 23
Study: 22356951

Group type: EXPERIMENTAL
Intervention: White obese avatar
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Black obese avatar
Number of subjects: 128

Group type: COMPARATOR
Intervention: White thin avatar
Number of subjects: 128

Group type: COMPARATOR
Intervention: Black thin avatar
Number of subjects: 128
Study: 19204523

Group type: EXPERIMENTAL
Intervention: Prior trauma history
Number of subjects: 1167

Group type: EXPERIMENTAL
Intervention: Lifetime psychiatric history
Number of subjects: 1167

Group type: EXPERIMENTAL
Intervention: Unintentional injury survivors with psychiatric history
Number of subjects: 1167
Study: 17666926

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) testing
Number of subjects: 225

Group type: COMPARATOR
Intervention: Routine laboratory analysis
Number of subjects: 225
Study: 16216821

Group type: EXPERIMENTAL
Intervention: Self management using a point of care device to measure INR twice a week and a dosing chart
Number of subjects: 617

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Self management
Number of subjects: 617
Study: 14589256

Group type: EXPERIMENTAL
Intervention: Medical care plus physical therapy
Number of subjects: 681

Group type: COMPARATOR
Intervention: Medical care only
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic care with physical modalities
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic care without physical modalities
Number of subjects: 681

Group type: COMPARATOR
Intervention: Medical care without physical therapy
Number of subjects: 681
Study: 10541320

Group type: EXPERIMENTAL
Intervention: Fetal vasculitis
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Maternal receipt of antibiotic in the 24 hours before delivery
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Placental membrane inflammation
Number of subjects: 1078
Study: 7698572

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Elemental formulas
Number of subjects: 413

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 413
Study: 2339012

Group type: EXPERIMENTAL
Intervention: lidocaine 5 mg/kg
Number of subjects: 7

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 7
Study: 526397

Group type: EXPERIMENTAL
Intervention: Intravenous administration of labetalol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral administration of labetalol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plasma levels of labetalol
Number of subjects: 12
Study: 31705466

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention, including the provision of a home BP monitor
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: CHW plus additional training in shared decision-making skills (DoMyPART)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: CHW plus additional training in self-management problem-solving (Problem Solving)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 159
Study: 30998227

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet consultations with individualized dietary glycemic load assessments using an app.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard dietary education according to the Chinese Dietary Guide for Pregnant Women (Control).
Number of subjects: 400